Iridex (IRIX) Common Equity (2011 - 2026)

Iridex has reported Common Equity for 16 years, with the latest figure at $3.6 million in Q3 2026.

• On a quarterly basis, Common Equity fell 39.94% year-over-year to $3.6 million in Q3 2026; TTM through Jul 2026 was $3.6 million, a 39.94% decrease from a year earlier, with the FY2026 full-year figure at $4.9 million, up 134.72% from the prior year.
• Common Equity was $3.6 million for Q3 2026 at Iridex, down from $4.7 million in the prior quarter.
• The five-year high for Common Equity was $23.3 million in Q1 2022, with the low at $852000.0 in Q1 2025.
• Average Common Equity over 5 years is $10.0 million, with a median of $6.5 million recorded in 2024.
• The sharpest annual moves came in 2025 and 2026: Common Equity tumbled 86.87% in 2025, then surged 455.4% in 2026.
• Over 5 years, Common Equity stood at $17.2 million in 2022, then slumped by 44.74% to $9.5 million in 2023, then tumbled by 77.98% to $2.1 million in 2024, then jumped by 123.22% to $4.7 million in 2025, then fell by 22.26% to $3.6 million in 2026.
• The last three Common Equity figures came in at $3.6 million (Q3 2026), $4.7 million (Q2 2026), and $4.9 million (Q1 2026), per Business Quant data.